Q3 FY26 results approved, board appoints Whole Time Director

Revenue DeclineEbitda Margin CompressionResults View source PDF Explain this filing

EMKAY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.1%Reaction day

₹278.00

prior close

₹272.10

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+0.9% vs market

Stockbroking & Allied peers, median of 38sector-0.1%+1.2% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.2 pts more than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.4

10m

+1.1

15m

+1.0

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.1+0.1+0.9-0.1+1.2

Next day

-5.4+2.2-7.6+2.3-7.7

-8.3+1.8-10.0+0.0-8.3

-9.7+3.6-13.3+0.2-9.9

-19.3+2.3-21.6-2.0-17.3

-14.4+6.1-20.5+2.0-16.4

-10.1+6.4-16.5+2.7-12.8

15d

-12.3+7.0-19.3-0.1-12.2

-16.2+3.8-19.9-3.0-13.2

-28.1-5.2-22.8-14.6-13.4

-14.9+12.5-27.4+0.2-15.1

UpDownMarket · Nifty Microcap 250Sector · Stockbroking & Allied peers, median of 38Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved unaudited Q3 FY26 results on Jan 27, 2026. Standalone Q3 PAT fell to Rs 313.08 lakhs vs Rs 985.80 last year. Nine-month PAT dropped to Rs 378.32 lakhs vs Rs 4,795.59. Revenue from operations declined to Rs 20,787.54 lakhs from Rs 24,832.15. Operating margin compressed sharply. Mr Raunak Karwa appointed Whole Time Director for 3 years effective Feb 1, 2026, subject to shareholder approval. Auditor gave clean limited review.

Likely market impact

Sharp fall in profits and revenue may weigh on stock. Director appointment signals succession. Major warrant and NCD issues dilute per share metrics.